MedTrace Logo

Amiodarone Usage After Ischemic Ventricular Tachycardia Ablation

NCT03244748 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2017-08-09

No results posted yet for this study

Summary

Ventricular Tachycardia ablation in ischemic cardiomyopathy patients is required procedure in cases when anti-arrhythmic drugs failed. The concern is if adjunctive continuation amiodarone after ablation is needed.

Conditions

  • Ischemic Cardiomyopathy
  • Ventricular Tachycardia
  • ICD Shock

Interventions

PROCEDURE

Ventricular tachycardia ablation

Electrophysiologic procedure aims to ablate and terminate arrhythmia percutaneously

Sponsors & Collaborators

  • Yuksek Ihtisas Hospital

    lead OTHER

Principal Investigators

  • Firat Ozcan, MD · MD

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2018-01-01
Completion
2018-03-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03244748 on ClinicalTrials.gov